Aromatase inhibitor drugs are used to treat breast cancer by reducing levels of estrogen in blood circulation. These inhibit the enzyme aromatase.
Aromatase inhibitor drugs are used to treat breast cancer by reducing levels of estrogen in blood circulation. These inhibit the enzyme aromatase. Androgens are converted to estrogen by aromatase. Less availability of estrogen reduces the stimulation of the growth of estrogen receptor (ER) positive breast cancer cells. Over 80% of all breast cancers are ER positive. Usage of aromatase inhibitors prevents ovaries from producing estrogen. Hence, these drugs are only used in the treatment of breast cancer in postmenopausal women. Uncontrolled growth of abnormal cells in many parts of the breast such as non-glandular tissue, small sacs that produce milk (lobules), and ducts that carry milk to the nipple is known as breast cancer. The two types of breast cancer are invasive and non-invasive. Invasive breast cancer is characterized by cancerous cells in the lining of the lobules or ducts. Due to invasive cancer cells, the surrounding tissues like skin, connective tissues, and fatty tissues become cancerous. Non-invasive breast cancer is characterized by cancerous cells in lobules or ducts.
Read Report Overview - https://www.transparencymarketresearch.com/aromatase-inhibitor-drugs-market.html
Rise in prevalence of breast cancer across the world boosts demand for aromatase inhibitor drugs. According to the Centers for Disease Control and Prevention (CDC), nearly 2,141 men and 236,968 women were diagnosed with breast cancer, and nearly 465 men and 41,211 women succumbed to the disease in the U.S. in 2014. According to the American Cancer Society, breast cancer accounted for 40,610 deaths, and 252,710 new invasive breast cancer and 63,410 non-invasive breast cancer cases were reported in 2017. According to Cancer Research UK, breast cancer accounted for 11,433 deaths in 2014, and 55,122 new cases of invasive breast cancer were registered in the U.K. in 2015. Increase in awareness about cancer drives demand for aromatase inhibitor drugs across the world. Rise in research and development on aromatase inhibitor drugs is attributed to the significant growth of the global aromatase inhibitor drugs market. According to The Pink Initiative, breast cancer accounted for 47,984 female deaths and 187,213 new cases were reported among women in China in 2012.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45039
The global aromatase inhibitor drugs market can be segmented based on product, distribution channel, and region. In terms of product, the market can be categorized into letrozole, exemestane, testolactone, and anastrozole. Based on distribution channel, the global aromatase inhibitor drugs market can be classified into retail pharmacies, online pharmacies, and hospital pharmacies.
Geographically, the global aromatase inhibitor drugs market can be categorized into Asia Pacific, Latin America, Europe, North America, and Middle East & Africa. North America held the largest market share owing to increase in health care expenditure and rise in prevalence of breast cancer. Europe held the second largest market share in 2017 due to increase in research and development on aromatase inhibitor drugs in the region. High incidence of breast cancer in developing countries and investment by key players in emerging economies with large patient population are anticipated to drive the market in Asia Pacific. The global aromatase inhibitor drugs market in Middle East & Africa is expected to be driven by rise in prevalence of breast cancer. The market in Latin America is expected to grow at a rapid pace during the forecast period from 2018 to 2026 due to increase in awareness about breast cancer among the people.
Pre Book Aromatase Inhibitor Drugs Market Report at - https://www.transparencymarketresearch.com/checkout.php?rep_id=45039<ype=S
Key players in the global aromatase inhibitor drugs market include Novartis AG, Bristol-Myers Squibb and Company, AstraZeneca, and Pfizer, Inc.
More Trending Reports by Transparency Market Research:
Orthodontic Elastics Market: Orthodontic rubber bands are used in coordination with metal braces in order to correct malocclusion such as overbites, underbites, cross bites, and open bites. They do so by spanning across the top and bottom arches. However, it is not as simple as just taking any rubber band and placing it on the brackets. Rather, there are specific types of bands, as well as different sizes that must be used to obtain the desired results.
Smart Stethoscopes Market: The smart stethoscope market is estimated to observe extensive growth across the assessment period of 2019-2027. The growing number of chronic diseases and cardiovascular disorders will prove to be good growth prospects for the smart stethoscope market. Furthermore, technological advancements will also prove to be profitable for the increase in the revenue of smart stethoscopes.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/